Public investments in environmental science are shown to be a major driver behind the UK’s wind industry. It delivers billions in economic value while also helping to protect the country’s marine environment.
Miles Tappin, VP of EMEA at ThreatConnect, discusses why it is essential for CISOs to explain to their fellow C-suite executives and board of directors how at risk their organisations actually are from cyber events.
The BlueInvest fund today allocated the first of an available €75 million to two projects working against food insecurity - announcing the names at a BlueInvest Day event.
New vaccine data from Israel suggests that the double-dose of Pfizer is performing at the expected rate of 95% efficiency - with the possibility that it is performing even better than that being further investigated.
Researchers have found that neurofeedback, or 'brain training', may be an effective treatment for individuals with post-traumatic stress disorder (PTSD).
In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.
The company announced that their current vaccine can handle the South African COVID mutation - with plans to create an "additional booster dose" to see if they can create specific protections against emerging variants.
The UK will offer its world-leading genomics expertise to identify new variants of the COVID-19 virus to countries who do not have the resources to do so.
Researchers are looking into Twitter whistle-blowers who raised concerns about suspicious 'pneumonia' cases, one month before the Chinese Government announced the existence of COVID-19.
Online courses have popped up in many different sectors but can they deliver what they promise, and how do attendees ensure they get the best results from enrolling on one of these courses?
Tomorrow (26 January) the COVID 'O' meeting is expected to be a moment of decision-making about border policy, as the more infectious South African and Brazilian COVID mutations continue to circulate.